Patientsville.com

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet Type your question here

 letters left

MIRTAZAPINE Safety Reports

Total MIRTAZAPINE reports: 574.
MIRTAZAPINE FDA safety alerts: 2003 2004 2005 .
Reported deaths: 99    Reported hospitalizations: 168.
Take MIRTAZAPINE Side Effects Survey or Share Your MIRTAZAPINE Story. Read More Here.

Showing 1-75 of 574 Next >

Consumer or non-health professional from AUSTRALIA reported MIRTAZAPINE problem on Jan 23, 2007. Male patient, 33 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, jaundice. MIRTAZAPINE dosage: unknown. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 25, 2007. Male patient, 79 years of age, weighting 168.0 lb, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: oedema, skin exfoliation. MIRTAZAPINE dosage: 30 MG, QD, ORAL. During the same period patient was treated with OMEPRAZOLE, WARFARIN. Patient recovered.

Consumer or non-health professional from SPAIN reported MIRTAZAPINE problem on Jan 25, 2007. Female patient, 82 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: confusional state, epilepsy, hyponatraemia. MIRTAZAPINE dosage: 30 MG. During the same period patient was treated with FUROSEMIDE, SPIRONOLACTONE, CLONAZEPAM, DIGOXIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from MEXICO on Jan 22, 2007. Female patient, 63 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. MIRTAZAPINE dosage: 15 MG, QD, UNK. During the same period patient was treated with FLUOXETINE. Patient recovered.

Consumer or non-health professional from MEXICO reported MIRTAZAPINE problem on Jan 22, 2007. Female patient, 50 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: restless legs syndrome. MIRTAZAPINE dosage: 15 MG, QD, UNK. During the same period patient was treated with FLUOXETINE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 26, 2007. Male patient, 39 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: aggression, anger. MIRTAZAPINE dosage: 15 MG, QD, ORAL. During the same period patient was treated with VENLAFAXINE, ZOPICLONE. Patient recovered.

Consumer or non-health professional from RUSSIAN FEDERATION reported MIRTAZAPINE problem on Jan 31, 2007. Male patient, 37 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, schizophrenia. MIRTAZAPINE dosage: unknown. Patient died.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 25, 2007. Male patient, 78 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: emotional distress, vision blurred, visual acuity reduced. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with DOXAZOSIN MESYLATE, LORAZEPAM, RAMIPRIL, SIMVASTATIN, WARFARIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Jan 30, 2007. Male patient, 64 years of age, weighting 205.0 lb, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose abnormal. MIRTAZAPINE dosage: 45 MG, ORAL. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from SPAIN on Jan 26, 2007. Female patient, 66 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, leukopenia, thrombocytopenia. MIRTAZAPINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Jan 26, 2007. Male patient, 39 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: aggression, anger. MIRTAZAPINE dosage: 15 MG ORAL. During the same period patient was treated with VENLAFAXINE, ZOPICLONE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 02, 2007. Male patient, 39 years of age, weighting 196.2 lb, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: eosinophil count increased, face oedema, impaired driving ability, joint swelling, weight increased. MIRTAZAPINE dosage: 15 MG, ORAL. During the same period patient was treated with TEGRETOL, VENTOLIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 02, 2007. Male patient, 39 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: eosinophil count increased, face oedema, fluid retention, impaired driving ability, joint swelling, weight increased. MIRTAZAPINE dosage: unknown. During the same period patient was treated with CARBMAZEPINE, SALBUTAMOL. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 01, 2007. Male patient, 64 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose abnormal. MIRTAZAPINE dosage: 45 MG. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported MIRTAZAPINE problem on Jan 31, 2007. Female patient, 29 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, chest pain, convulsion, ear disorder, eye disorder, flank pain, haemorrhage, headache, hyperkinesia. MIRTAZAPINE dosage: 45 MG. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Male patient, 40 years of age, weighting 254.2 lb, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis. MIRTAZAPINE dosage: unknown. Patient recovered.

Consumer or non-health professional from CANADA reported MIRTAZAPINE problem on Feb 07, 2007. Male patient, 74 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. MIRTAZAPINE dosage: 60 MG, ORAL. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient died.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 08, 2007. Female patient, 55 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, gait disturbance, peripheral coldness, suicidal ideation. MIRTAZAPINE dosage: 15 MG, ORAL. During the same period patient was treated with ATENOLOL, DULOXETINE HYDROCHLORIDE. Patient recovered.

Consumer or non-health professional from SWEDEN reported MIRTAZAPINE problem on Feb 09, 2007. Male patient, 56 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from CANADA on Feb 07, 2007. Female patient, 53 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: back pain, gait disturbance, myalgia. MIRTAZAPINE dosage: 30 MG,. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ZOPICLONE, SERTRALINE HYDROCHLORIDE. Patient recovered.

Consumer or non-health professional from SPAIN reported MIRTAZAPINE problem on Feb 07, 2007. Female patient, 77 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: retinal vein thrombosis. MIRTAZAPINE dosage: 30 MG QD; ORAL. During the same period patient was treated with ANEUROL. Patient was hospitalized and became disabled. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from NORWAY on Feb 05, 2007. Female patient, 33 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. MIRTAZAPINE dosage: 15 MG QD; ORAL. Patient died.

Consumer or non-health professional from SPAIN reported MIRTAZAPINE problem on Jan 24, 2007. Female patient, 82 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, convulsion, hyponatraemia, white blood cell count increased. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with FUROSEMIDE, SPIRONOLACTONE, CLONAZEPAM, DIGOXIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from SPAIN on Jan 26, 2007. Female patient, 66 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, leukopenia, thrombocytopenia, vitamin b12 decreased. MIRTAZAPINE dosage: unknown. Patient recovered.

Consumer or non-health professional from CANADA reported MIRTAZAPINE problem on Feb 07, 2007. Female patient, 85 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: burning sensation, pruritus. MIRTAZAPINE dosage: unknown. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from NORWAY on Feb 05, 2007. Female patient, 33 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. MIRTAZAPINE dosage: 15 MG QD. Patient died.

Health Professional from UNITED STATES reported MIRTAZAPINE problem on Feb 09, 2007. Male patient, 61 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: back pain, inflammation, loss of consciousness, osteoarthritis, overdose. MIRTAZAPINE dosage: unknown. During the same period patient was treated with FENTANYL, CODEINE, CITALOPRAM HYDROBROMIDE, HYDROCODONE, TIZANIDINE, LORAZEPAM, DEPAKOTE, ZOLPIDEM. Patient died.

MIRTAZAPINE problem was reported by a Health Professional from UNITED STATES on Feb 09, 2007. Female patient, 52 years of age, was diagnosed with depression, schizophrenia and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, calcinosis, hypertensive heart disease, pulmonary congestion, suicidal ideation, suicide attempt, thyroid neoplasm. MIRTAZAPINE dosage: unknown. During the same period patient was treated with DESIPRAMINE, ZIPRASIDONE, LEVOTHYROXINE, LORAZEPAM, METHAMPHETAMINE HYDROCHLORIDE. Patient died.

Health Professional from UNITED STATES reported MIRTAZAPINE problem on Feb 09, 2007. Female patient, 62 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, completed suicide, depression, pulmonary congestion, pulmonary oedema, suicidal ideation. MIRTAZAPINE dosage: unknown. During the same period patient was treated with HYDROCODONE, QUETIAPINE FUMARATE, DIPHENHYDRAMINE, TEMAZEPAM. Patient died.

MIRTAZAPINE problem was reported by a Health Professional from UNITED STATES on Feb 09, 2007. Male patient, 25 years of age, weighting 159.0 lb, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, injury, overdose. MIRTAZAPINE dosage: unknown. During the same period patient was treated with VENLAFAXINE. Patient died.

Health Professional from UNITED STATES reported MIRTAZAPINE problem on Feb 09, 2007. Female patient, 78 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anger, completed suicide. MIRTAZAPINE dosage: unknown. During the same period patient was treated with PROPOXYPHENE HYDROCHLORIDE, ALPRAZOLAM. Patient died.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 13, 2007. Female patient, 55 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anorexia, gait disturbance, muscular weakness, peripheral coldness, suicidal ideation. MIRTAZAPINE dosage: 15 MG; QD; PO. During the same period patient was treated with ATENOLOL, DULOXETINE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 07, 2007. Female patient, 29 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: raynaud's phenomenon. MIRTAZAPINE dosage: 45 MG;QD;PO. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Female patient, 81 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: asthenia, electrolyte imbalance, fall, inappropriate antidiuretic hormone secretion. MIRTAZAPINE dosage: unknown. During the same period patient was treated with ESCITALOPRAM, HYDROCHLOROTHIAZIDE, RAMIPRIL, DONEPEZIL, ALENDRONIC ACID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported MIRTAZAPINE problem on Feb 08, 2007. Male patient, 63 years of age, was diagnosed with depression, arthralgia and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: serotonin syndrome. MIRTAZAPINE dosage: 60 MG. During the same period patient was treated with CELECOXIB, LITHIUM CARBONATE, TRAMADOL, LITHIUM CARBONATE, VALERIANA OFFICINALIS, TIZANIDINE, LORAZEPAM, LACTULOSE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on Feb 08, 2007. Female patient, 72 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: serotonin syndrome. MIRTAZAPINE dosage: 15 MG/30 MG/45 MG/30 MG/15 MG. During the same period patient was treated with PIPAMPERONE, VENLAFAXINE HYDROCHLORIDE, DONEPEZIL. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 10, 2007. Female patient, 29 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: raynaud's phenomenon. MIRTAZAPINE dosage: 45 MG (45 MG, 1 IN 1 D). Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Female patient, 86 years of age, weighting 84.88 lb, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: asthma, clostridium colitis, dementia, depression, fall, hip arthroplasty, kidney infection, pulmonary oedema, suicidal ideation. MIRTAZAPINE dosage: 30 MG, QHS; ORAL; 30 MG QHS; ORAL. During the same period patient was treated with MAXZIDE, NAMENDA, ALBUTEROL, ARICEPT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SPAIN reported MIRTAZAPINE problem on Feb 14, 2007. Female patient, 66 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, fatigue, haemolytic anaemia, leukopenia, thrombocytopenia. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with DEFLAZACORT, BROMAZEPAM, BENTAZEPAM, METFORMIN. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from MEXICO on Feb 16, 2007. Female patient, 44 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anorexia, fatigue, gait disturbance, hypersensitivity, laryngospasm, palpitations, paraesthesia, pneumonia, pulmonary oedema. MIRTAZAPINE dosage: 15 MG/30 MG ORAL. During the same period patient was treated with CYMBALTA, OXCARBAZEPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 22, 2007. Female patient, 55 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abasia, anorexia, feeling abnormal, feeling cold, muscular weakness, peripheral coldness. MIRTAZAPINE dosage: 15 MG ORAL. During the same period patient was treated with ATENOLOL, DULOXETINE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 13, 2007. Female patient, 48 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. MIRTAZAPINE dosage: unknown. During the same period patient was treated with EPANUTIN. Patient recovered.

Consumer or non-health professional from MEXICO reported MIRTAZAPINE problem on Feb 22, 2007. Female patient, 44 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anorexia, balance disorder, fatigue, gait disturbance, hemiparesis, hypersensitivity, laryngospasm, palpitations, paraesthesia. MIRTAZAPINE dosage: 15 MG/30 MG ORAL. During the same period patient was treated with OXCARBAZEPINE, CYMBALTA. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from CZECH REPUBLIC on Dec 20, 2005. Female patient, 41 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. MIRTAZAPINE dosage: unknown. During the same period patient was treated with AMISULPRIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 19, 2007. Female patient, 43 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: akathisia, lip swelling, swollen tongue. MIRTAZAPINE dosage: 15 MG ORAL. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 19, 2007. Female patient was diagnosed with depressed mood and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: depressed mood, depression, headache, hyperhidrosis, inappropriate affect, insomnia, irritability, nausea. MIRTAZAPINE dosage: unknown. During the same period patient was treated with PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, BUSPIRONE, GABAPENTIN, PROPRANOLOL. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 19, 2007. Female patient, 48 years of age, was diagnosed with epilepsy and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. MIRTAZAPINE dosage: unknown. During the same period patient was treated with PHENYTOIN. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWEDEN on Feb 19, 2007. Female patient, 53 years of age, was diagnosed with depression, contraception and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: angina pectoris, haemorrhage, insomnia, respiratory disorder. MIRTAZAPINE dosage: unknown. During the same period patient was treated with MARVELON. Patient recovered.

Health Professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 22, 2007. Male patient, 64 years of age, weighting 205.0 lb, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. MIRTAZAPINE dosage: 45 MG, ORAL. During the same period patient was treated with ADALAT, ALLOPURINOL, ATENOLOL, ATORVASTATIN CALCIUM, CLOPIDOGREL, DOXAZOSIN, FUROSEMIDE, GLICLAZIDE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from NORWAY on Feb 22, 2007. Female patient, 52 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. MIRTAZAPINE dosage: unknown. During the same period patient was treated with ESCITALOPRAM. Patient recovered.

Consumer or non-health professional from SPAIN reported MIRTAZAPINE problem on Feb 22, 2007. Male patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. MIRTAZAPINE dosage: unknown. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Male patient, 61 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, inflammation, liver disorder, loss of consciousness, pulmonary oedema, visceral congestion. MIRTAZAPINE dosage: unknown. During the same period patient was treated with FENTANYL, TIZANIDINE, LORAZEPAM, DEPAKOTE, ZOLPIDEM, ESCITALOPRAM, ACETAMINOPHEN AND HYDROCODONE BITARTRATE, DOXEPIN. Patient died.

Consumer or non-health professional from UNITED STATES reported MIRTAZAPINE problem on Feb 20, 2007. Female patient, 52 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: calcinosis, completed suicide, overdose, pulmonary congestion, pulmonary oedema, thyroid neoplasm. MIRTAZAPINE dosage: unknown. During the same period patient was treated with ZIPRASIDONE, LEVOTHYROXINE, LORAZEPAM, DESIPRAMINE. Patient died.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 62 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, oedema, pulmonary congestion. MIRTAZAPINE dosage: unknown. During the same period patient was treated with HYDROCODONE, DIPHENHYDRAMINE, QUETIAPINE FUMARATE, TEMAZEPAM. Patient died.

Consumer or non-health professional from FRANCE reported MIRTAZAPINE problem on Feb 22, 2007. Female patient, 61 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ZOLPIDEM, OXAZEPAM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 22, 2007. Female patient, 55 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, dizziness, feeling cold, gait disturbance, malaise, movement disorder, peripheral coldness, suicidal ideation. MIRTAZAPINE dosage: 15 MG ONCE/7.5 MG ONCE ORAL. During the same period patient was treated with ATENOLOL, DULOXETINE. Patient recovered.

Consumer or non-health professional from IRELAND reported MIRTAZAPINE problem on Feb 23, 2007. Female patient, 51 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: extrasystoles, flushing. MIRTAZAPINE dosage: 30 MG QD, ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, ALPRAZOLAM, ALVESCO, TRETINOIN, SALBUTAMOL. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 27, 2007. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. MIRTAZAPINE dosage: 60 MG; QD; PO. During the same period patient was treated with QUETIAPINE FUMARATE. Patient recovered.

Consumer or non-health professional from SWEDEN reported MIRTAZAPINE problem on Feb 26, 2007. Male patient, 56 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 26, 2007. Male patient, 64 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation, glycosylated haemoglobin increased. MIRTAZAPINE dosage: unknown. During the same period patient was treated with NIFEDIPINE, ALLOPURINOL, ATENOLOL, ATORVASTATIN CALCIUM, CLOPIDOGREL, DOXAZOSIN MESYLATE, FUROSEMIDE, GLICLAZIDE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Mar 06, 2007. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. MIRTAZAPINE dosage: 60 MG ORAL. During the same period patient was treated with QUETIAPINE FUMARATE. Patient was hospitalized and became disabled. Patient recovered.

MIRTAZAPINE problem was reported by a Health Professional from UNITED STATES on Feb 26, 2007. Female patient, 86 years of age, weighting 85.00 lb, was diagnosed with dementia, depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: asthma, clostridium difficile colitis, condition aggravated, dementia, depression, fall, hip arthroplasty, kidney infection, pulmonary oedema. MIRTAZAPINE dosage: unknown. During the same period patient was treated with MAXZIDE, DONEPEZIL, SALBUTAMOL SULPHATE, NAMENDA. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported MIRTAZAPINE problem on Mar 15, 2007. Male patient, 78 years of age, weighting 160.3 lb, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: akathisia, somnolence, suicidal ideation. MIRTAZAPINE dosage: unknown. Patient recovered.

MIRTAZAPINE problem was reported by a Health Professional from UNITED KINGDOM on Feb 27, 2007. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. MIRTAZAPINE dosage: 60 MG, UNK, ORAL. During the same period patient was treated with QUETIAPINE FUMARATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Mar 02, 2007. Female patient, 37 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: malaise, pleural fibrosis, red blood cell sedimentation rate increased. MIRTAZAPINE dosage: unknown. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on Mar 02, 2007. Female patient, 54 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: agitation, depersonalisation, derealisation, dizziness, feeling abnormal. MIRTAZAPINE dosage: 30 MG QD ORAL. During the same period patient was treated with NEBIVOLOL HYDROCHLORIDE, CHONDROITIN SULPHATE, ESTRADIOL. Patient recovered.

Consumer or non-health professional from GREECE reported MIRTAZAPINE problem on Mar 05, 2007. Female patient, 68 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, oedema mouth. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with LOSARTAN POTASSIUM, FRUMIL, ALPRAZOLAM, ATORVASTATIN CALCIUM. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 06, 2007. Female patient, 36 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. MIRTAZAPINE dosage: 3.75 MG. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Mar 06, 2007. Male patient, 48 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: overdose. MIRTAZAPINE dosage: unknown. Patient was hospitalized. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from SPAIN on Mar 01, 2007. Female patient, 76 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, chronic hepatitis, condition aggravated. MIRTAZAPINE dosage: 30 MG QD. During the same period patient was treated with ALPRAZOLAM, FUROSEMIDE, POTASSIUM CHLORIDE, CITALOPRAM HYDROBROMIDE, BISOPROLOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Mar 09, 2007. Female patient, 40 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: angioedema. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with DICLOFENAC, DOTHIEPIN HYDROCHLORIDE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWEDEN on Mar 09, 2007. Male patient, 56 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Mar 09, 2007. Female patient, 29 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: raynaud's phenomenon. MIRTAZAPINE dosage: 45 MG QD ORAL. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.

MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 09, 2007. Female patient, 23 years of age, was diagnosed with anxiety, depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hallucination, nightmare, sleep disorder, sleep paralysis. MIRTAZAPINE dosage: 15 MG/30 MG ORAL. During the same period patient was treated with DIAZEPAM, ERYTHROMYCIN, FLOXACILLIN, KOLANTICON, PROMAZINE HYDROCHLORIDE. Patient recovered.

Consumer or non-health professional from FRANCE reported MIRTAZAPINE problem on Mar 09, 2007. Female patient, 61 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ZOLPIDEM, OXAZEPAM, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Showing 1-75 of 574 Next >